TCRR Annual Non Current Assets
$30.61 M
-$16.63 M-35.20%
31 December 2022
Summary:
As of February 5, 2025, TCRR annual long term assets is $30.61 million, with the most recent change of -$16.63 million (-35.20%) on December 31, 2022. During the last 3 years, it has risen by +$25.27 million (+472.99%).TCRR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRR Quarterly Non Current Assets
$11.02 M
-$19.59 M-64.00%
31 March 2023
Summary:
As of February 5, 2025, TCRR quarterly long term assets is $11.02 million, with the most recent change of -$19.59 million (-64.00%) on March 31, 2023. Over the past year, it has dropped by -$64.92 million (-85.49%).TCRR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRR Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -35.2% | -85.5% |
3 y3 years | +473.0% | -45.8% |
5 y5 years | +2191.5% | - |
TCRR Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -35.2% | -88.0% |
TCR2 Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | $11.02 M(-64.0%) |
Dec 2022 | $177.62 M(-35.7%) | $30.61 M(-65.5%) |
Sept 2022 | - | $88.85 M(-3.7%) |
June 2022 | - | $92.21 M(+21.4%) |
Mar 2022 | - | $75.94 M(+60.7%) |
Dec 2021 | $276.13 M(+17.2%) | $47.24 M(+8.6%) |
Sept 2021 | - | $43.51 M(+1.4%) |
June 2021 | - | $42.91 M(-19.4%) |
Mar 2021 | - | $53.21 M(+399.3%) |
Dec 2020 | $235.54 M | $10.66 M(+61.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $6.62 M(+0.2%) |
June 2020 | - | $6.61 M(-67.5%) |
Mar 2020 | - | $20.35 M(+280.8%) |
Dec 2019 | $163.19 M(+30.0%) | $5.34 M(-58.6%) |
Sept 2019 | - | $12.89 M(-11.6%) |
June 2019 | - | $14.58 M(-54.8%) |
Mar 2019 | - | $32.27 M(+719.1%) |
Dec 2018 | $125.49 M(+506.2%) | $3.94 M(+20.2%) |
Sept 2018 | - | $3.28 M(+145.4%) |
Dec 2017 | $20.70 M(+19.6%) | $1.34 M |
Dec 2016 | $17.32 M | - |
FAQ
- What is TCR2 Therapeutics annual long term assets?
- What is the all time high annual non current assets for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual non current assets year-on-year change?
- What is TCR2 Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly non current assets year-on-year change?
What is TCR2 Therapeutics annual long term assets?
The current annual non current assets of TCRR is $30.61 M
What is the all time high annual non current assets for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual long term assets is $47.24 M
What is TCR2 Therapeutics annual non current assets year-on-year change?
Over the past year, TCRR annual long term assets has changed by -$16.63 M (-35.20%)
What is TCR2 Therapeutics quarterly long term assets?
The current quarterly non current assets of TCRR is $11.02 M
What is the all time high quarterly non current assets for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly long term assets is $92.21 M
What is TCR2 Therapeutics quarterly non current assets year-on-year change?
Over the past year, TCRR quarterly long term assets has changed by -$64.92 M (-85.49%)